Literature DB >> 8640905

An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico.

Y Soini1, S C Chia, W P Bennett, J D Groopman, J S Wang, V M DeBenedetti, H Cawley, J A Welsh, C Hansen, N V Bergasa, E A Jones, A M DiBisceglie, G E Trivers, C A Sandoval, I E Calderon, L E Munoz Espinosa, C C Harris.   

Abstract

The p53 tumor suppressor gene is commonly mutated in human hepatocellular carcinoma (HCC). The most frequent mutation in HCC in populations exposed to a high dietary intake of aflatoxin B1 (AFB1) is an AGGarg-->AGTser missense mutation in codon 249 of the p53 gene. We analyzed HCCs from Monterrey, Mexico, for the codon 249ser hotspot mutation. We also analyzed the serum AFB1-albumin adduct levels of the donors and family members to measure the current AFB1 exposure in this population. Moreover, the presence of hepatitis B and/or C viral infection (HBV or HCV) was analyzed serologically in the patients. Tumor cells were microdissected from tissue sections and exon 7 p53 sequences were amplified by polymerase chain reaction from genomic DNA and sequenced directly. The serological tests for anti-p53 antibodies, HBV or HCV were done by ELISA. Immunohistochemical analysis of p53 protein was done using a polyclonal rabbit antiserum (CM-1). Eight of 21 cases were positive by p53 immunohistochemistry. Of the 16 cases sequenced for exon 7 of p53 three codon 249 AGGarg-->AGTser mutations were found. Serum antibodies recognizing p53 protein were found in one of 18 patients. Positive serology for HBV and/or HCV was found in 12 of 20 cases. The serum AFB1-albumin adduct levels in this population ranged from 0.54 to 4.64 pmol aflatoxin/mg albumin. These results indicate that dietary AFB1 and hepatitis viruses are etiological agents in the molecular pathogenesis of HCC in this geographic region of Mexico.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8640905     DOI: 10.1093/carcin/17.5.1007

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  28 in total

1.  Prevalence of Aflatoxin-Associated TP53R249S Mutation in Hepatocellular Carcinoma in Hispanics in South Texas.

Authors:  Jingjing Jiao; Weibo Niu; Ying Wang; Keith Baggerly; Yuanqing Ye; Xifeng Wu; Dewitt Davenport; Jose Luis Almeda; Monica M Betancourt-Garcia; R Armour Forse; Heather L Stevenson; Gordon P Watt; Joseph B McCormick; Susan P Fisher-Hoch; Laura Beretta
Journal:  Cancer Prev Res (Phila)       Date:  2017-10-31

2.  Codon 249 mutations of p53 gene in development of hepatocellular carcinoma.

Authors:  Xiao-Mou Peng; Wen-Wei Peng; Ji-Lu Yao
Journal:  World J Gastroenterol       Date:  1998-04       Impact factor: 5.742

3.  Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis.

Authors:  L W Elmore; A R Hancock; S F Chang; X W Wang; S Chang; C P Callahan; D A Geller; H Will; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

4.  Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignancies.

Authors:  James P Hamilton
Journal:  Epigenomics       Date:  2010-04-01       Impact factor: 4.778

Review 5.  Aflatoxins, hepatocellular carcinoma and public health.

Authors:  Arvin Magnussen; Mansour A Parsi
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

6.  The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation.

Authors:  Lorne J Hofseth; Mohammed A Khan; Mark Ambrose; Olga Nikolayeva; Meng Xu-Welliver; Maria Kartalou; S Perwez Hussain; Richard B Roth; Xiaoling Zhou; Leah E Mechanic; Irit Zurer; Varda Rotter; Leona D Samson; Curtis C Harris
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

7.  Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling.

Authors:  Yuki Katayama; Moegi Maeda; Ken Miyaguchi; Shota Nemoto; Mahmut Yasen; Shinji Tanaka; Hiroshi Mizushima; Yutaka Fukuoka; Shigeki Arii; Hiroshi Tanaka
Journal:  Oncol Lett       Date:  2012-07-18       Impact factor: 2.967

Review 8.  p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy.

Authors:  Neda Slade; Ute M Moll; Branko Brdar; Arijana Zorić; Bojan Jelaković
Journal:  Mutat Res       Date:  2009-02-04       Impact factor: 2.433

9.  Structural perturbations induced by the alpha-anomer of the aflatoxin B(1) formamidopyrimidine adduct in duplex and single-strand DNA.

Authors:  Kyle L Brown; Markus W Voehler; Shane M Magee; Constance M Harris; Thomas M Harris; Michael P Stone
Journal:  J Am Chem Soc       Date:  2009-11-11       Impact factor: 15.419

10.  249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients.

Authors:  Jeronimo A Nogueira; Suzane K Ono-Nita; Marcelo E Nita; Marcelo M T de Souza; Eliane P do Carmo; Evandro S Mello; Cristovan Scapulatempo; Denise C Paranaguá-Vezozzo; Flair J Carrilho; Venancio A F Alves
Journal:  BMC Cancer       Date:  2009-06-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.